FDA Commissioner Marty Makary and biologics chief Vinay Prasad have sketched out the agency’s first real blueprint for ...

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Critics, including some drugmakers, argue that new patent policies would make it more difficult for companies to bring ...

Read more from STAT’s Chelsea Cirruzzo and Daniel Payne for more details on what Vance had to say and what attendees received ...

The CEO of the drugmaker Uniqure told investors at a private dinner that the Trump White House “doesn’t like all the drama” ...

December will be a consequential month for Agios Pharmaceuticals and its effort to expand the use and sales of its ...

New policies rolled out by the U.S. patent office polices may make it harder for lower-cost medicines to reach consumers, ...

Republicans want to replace enhanced ACA tax credits with direct payments to individuals. Their think tank allies aren’t so ...

These digital barriers create stark state-level variation in access, with direct consequences for seniors. The gaps show up ...

The question now is how to best serve the millions who, freed from a lifetime of yo-yo dieting, are re-engaging with their ...

News on Microsoft's "humanist superintelligence," Medicare's AI vendors, and more in this week's AI Prognosis newsletter.

Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to ...